Cost of vaccination has risen 68 times in a decade, says report

Crisis looms as donor withdraws support to African countries; MSF urges GSK, Pfizer to slash vaccine price

Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth

Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …

DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered

CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections

Strong medicine for weak drug patents

Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend

Make unethical drug trials a punishable offence, say experts

Current laws do not fix penalty if such practices are found

The natco-pfizer test

Natco’s demand for a voluntary licence from Pfizer will establish how well the compulsory licence process works in India

Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred

Both manufacturers have been asked for more data before a final decision can be reached  

Drug affordability test

Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …

The world needs pharmaceuticals from China and India to beat COVID-19

Chinese manufacturers make around 40% of all APIs used worldwide; China, India are the source of 75-80% of APIs imported to US

Big pharma’s dirty tricks

Drug giants from GSK, Abbott and Pfizer to Bayer have been fined for serious malpractices. They should be under close watch in India

Standing up to the US

India does not have to be apologetic about its patents law, which is fully compliant with WTO requirements on intellectual property protection

Drug trials: Irked NHRC issues notices to Centre and Andhra Pradesh government

Says respond else face action

US piles on the pressure

Patent law, domestic content rules in solar and ICT policy come under attack